Empagliflozin Film-Coated Tablets 25 mg ,JARDIANCE
Sponsors
Bio-innova Co., Ltd.
Conditions
Healthy volunteers, A Bioequivalence safety study
Bioequivalence Empagliflozin Film-Coated Tablets 25 mgThe study is conducted in healthy Thai human volunteers to improve glycemic
Bioequivalence Empagliflozin Film-Coated Tablets 25 mg
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Empagliflozin Film-Coated Tablets 25 mg relative to JARDIANCE (Empagliflozin Film-Coated Tablets 25 mg) in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20250611005
Start: 2025-11-18Target: 28Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Empagliflozin Film-Coated Tablets 25 mg relative to JARDIANCE (Empagliflozin Film-Coated Tablets 25 mg) in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20251107001
Start: 2026-05-28Target: 28Updated: 2026-08-03